HomeOpen Access NewsHealth & Social Care

Health & Social Care

AI lung cancer diagnostic pathway redesign in North East London

Surabhi Srivastava, Commercial Head UK and EU at Qure.ai, discusses how integrating artificial intelligence can reduce chest X-ray reporting times and accelerate early lung cancer diagnosis.

Protecting ageing synapses through exercise

Keeping the ageing population as active as possible, enhances the connections between neurons to maintain healthy cognition.

More trusting societies have greater success managing COVID-19

Research has found that countries with higher success in minimising coronavirus cases and deaths, have more trust within their society and governments.

NHS backlog to be resolved by 2025 in “most optimistic scenario”

A Health Committee report finds that in the "most optimistic scenario" of increased treatment over the next three years, the NHS backlog could come down to pre-pandemic levels in 2025.

Climate change disproportionately impacts Indigenous communities

Research by the University of Waterloo reveals that Indigenous communities are at higher risk from climate change flooding, due to pre-existing socioeconomic vulnerability.

Study shows fourth booster dose increases antibodies fivefold

In Israel, healthcare professionals and those over 60 are now being encouraged to take the fourth booster dose - which appears to significantly increase waning third dose antibodies.

UK appoints Women’s Health Ambassador to tackle gender health gap

The government are appointing a Women’s Health Ambassador to demonstrate stronger support for women’s health, as well as focusing on ending violence against women.

Scientists to identify depression and antidepressant efficiency via blood tests

Researchers at the University of Chicago are believed to be one step closer in the development of blood tests to identify depression.

Study finds young COVID patients have increased oxidative stress

According to new data, even young COVID patients have increased oxidative stress - a factor connected to ageing, diabetes and HIV.

Convidecia vaccine 57.5% effective against symptomatic COVID

Phase Three trial shows Convidecia vaccine 57.5% effective against symptomatic COVID, while 91.7% effective against severe COVID.

Study identifies factors in blood linked to severe COVID

Unique “indicators” in the blood of patients with severe and fatal COVID could create simple diagnostic tests - to help doctors identify who could become critically ill.

European Commission approves Novavax COVID vaccine for use

The Commission gave a conditional marketing authorisation (CMA) to the Novavax COVID vaccine, with 100 million doses expected in early 2022.

Chronic pain is the norm for 50% of people with long-term conditions

According to a UK study, those with multimorbidity are statistically between two and four times as likely to experience chronic pain.

Scientists say AstraZeneca protection decreases after three months

According to data from two million people in Scotland and 42 million people in Brazil, AstraZeneca vaccine protection drops significantly three months after double-dosing.

Study says prior infection gives 19% protection against Omicron

COVID infection previously created 85% protection against Delta - now, scientists say that this protection falls to 19% against Omicron.

What are the side effects of the Moderna booster vaccine?

Here, we explain side effects of the Moderna booster vaccine - while taking a look at the Omicron variant.

How remote patient monitoring can improve health outcomes for people with diabetes

Glooko reveals how remote patient monitoring technologies to manage diabetes and related chronic conditions are delivering long-term benefits and will likely become part of standard at-home care management.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders